7-hydroxymitragynine legality 2026, DEA scheduling 7-oh, kratom extract laws, 7-oh ban
The regulatory environment for 7-Hydroxymitragynine (7-OH) has entered its most turbulent phase yet. For consumers, retailers, and laboratory researchers across the United States, keeping up with the legal status of this potent botanical extract has become a moving target.
Following unprecedented crackdowns by state health departments and landmark actions at the federal level, the legal parameters for buying, selling, or possessing 7-OH have tightened significantly.
If you are asking, “Is 7-OH legal near me?“, this comprehensive legal breakdown explores the federal rulings and shifting state-level policies.
The Federal Landscape: The July 2026 DEA Notices of Intent
The biggest shift in 7-OH history occurred at the federal level. The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) formally commended the Drug Enforcement Administration (DEA) for issuing two critical Notices of Intent (NOIs) to begin the temporary scheduling process for concentrated kratom-related compounds.
The regulatory landscape shifted permanently when the U.S. Drug Enforcement Administration filed its intent to temporarily place 7-hydroxymitragynine (7-OH) and three related substances into Schedule I of the Controlled Substances Act.
Published officially in the Federal Register, the federal framework addresses two distinct categories:
Concentrated 7-OH Above a Specified Threshold
The DEA intends to temporarily place 7-hydroxymitragynine formulations that exceed a specific concentration threshold into Schedule I of the Controlled Substances Act (CSA). The temporary order seeks to establish what concentration or quantity of 7-OH constitutes an imminent hazard to public safety without capturing standard, unadulterated raw leaf kratom.
Synthetic 7-OH Derivatives
The federal government is initiating a total, temporary Schedule I ban on three specific synthetic derivatives that do not occur naturally within the plant:
- Mitragynine pseudoindoxyl (MP): A chemical rearrangement product of 7-OH.
- Dihydro-7-hydroxymitragynine (MGM-15): A highly potent synthetic variant.
- 9-fluoro derivative of 7-hydroxymitragynine (MGM-16): An engineered synthetic analog.
What this means for buyers: The federal government is aggressively moving to eliminate highly concentrated, artificially spiked, and completely synthetic “designer” compounds from the marketplace. These rules are designed to protect public health while leaving natural, traditional kratom leaf (which contains only microscopic trace amounts of 7-OH) unaffected.
State-Level Dynamic: Aggressive Local Crackdowns
While the federal government reviews public comments on scheduling thresholds, individual states have executed sweeping enforcement protocols. The legal status of 7-OH depends entirely on your zip code.
California’s Consumer Protection Initiative
The California Department of Public Health (CDPH) and the Department of Alcoholic Beverage Control (ABC) executed statewide operations to remove non-compliant items from shelves under the authority of the Sherman Food, Drug, and Cosmetic Act. State regulators have clarified that manufacturing or selling concentrated, standalone 7-OH products as food or dietary supplements is unauthorized in the state, leading to the seizure of millions of dollars in inventory.
Florida’s Ratio and Dosing Limits
Florida took an emergency regulatory route. Rather than an outright ban on all related botanical extracts, Florida enforces a strict ratio architecture:
No product may contain more than 1 milligram of 7-OH per gram or milliliter.
- Any product containing 7-OH must contain at least 100 times more mitragynine (MIT) by mass.
- This rule mathematically eliminates “super-concentrated” or isolated 7-OH shots and tablets, forcing manufacturers to stick exclusively to natural, un-spiked whole-plant ratios.
Kansas and Pre-Existing Bans
Effective July 1, 2026, Kansas completely classified isolated 7-OH and kratom extracts as Schedule I controlled substances under state law, introducing strict criminal penalties for possession, sale, or purchase.
Comprehensive State Legality Tracker
To help you navigate where 7-hydroxymitragynine and high-potency extracts face legal boundaries, consult the overview below:
| Jurisdiction Level | Legal Status | Notes / Limitations |
| Total Ban States | Illegal | Alabama, Arkansas, Indiana, Kansas, Louisiana, Mississippi, Rhode Island, Vermont, and Wisconsin. |
| Strict Limitation States | Restricted | Florida: Outlaws products exceeding 1mg/g of 7-OH or lacking a 100:1 MIT-to-7-OH mass ratio. California: Strictly enforces bans on concentrated 7-OH sold as foods or supplements. |
| Kratom Consumer Protection Act (KCPA) States | Legal with Age Limits | Over 20 states regulate via the KCPA. 7-OH must be derived from natural extraction, explicitly labeled, and restricted to adults aged 21+. |
| Banned Municipalities | Illegal Locally | Major local exceptions exist regardless of state laws. Examples include San Diego (CA), Denver (CO), Alton (IL), and Union County (MS). |
How Consumers Can Stay Safe and Compliant
The days of purchasing unverified, unlabeled mystery foils at local convenience counters are over. To protect your health and stay compliant with evolving laws, follow these sourcing protocols:
- Verify Botanical Authenticity: Ensure the brand explicitly states that their products are derived naturally from Mitragyna speciosa and do not incorporate synthetic molecules like MP or MGM-15.
- Demand a Threshold-Specific COA: Review the independent lab results. Ensure the total milligram count matches state laws and reflects strict, compliant dosing rather than illegal chemical enhancement.
- Respect Age and Regional Restrictions: Never attempt to order or transport these specialized extracts across state or municipal lines where explicit prohibitions exist.
Standard Disclaimer
The regulatory landscape surrounding 7-hydroxymitragynine is subject to rapid change. This article is intended solely for educational and informational purposes and does not constitute formal legal advice. Always review federal, state, and local statutes directly to ensure compliance.